Side-by-side financials for ATRA and ARGX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ATRA | ARGX |
|---|---|---|
| Market cap | - | $55.29 B |
| US-listed rank | - | #303 |
| Revenue (latest FY) | $120.77M | - |
| Net income (latest FY) | $32.69M | - |
| Net margin | 27.1% | - |
| SEC filings | 999 | 272 |
Full pages: Atara Biotherapeutics, Inc. and ARGENX SE, or browse the full rankings.